XNYS:BMY Bristol-Myers Squibb Company Insider Activity 4 Filing - 3/6/2012

Effective Date 3/6/2012

XNYS:BMY Fair Value Estimate
Premium
XNYS:BMY Consider Buying
Premium
XNYS:BMY Consider Selling
Premium
XNYS:BMY Fair Value Uncertainty
Premium
XNYS:BMY Economic Moat
Premium
XNYS:BMY Stewardship
Premium
 
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Celentano John E
  2. Issuer Name and Ticker or Trading Symbol
BRISTOL MYERS SQUIBB CO [BMY]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
SVP HR Public Affairs & Philan
(Last)
(First)
(Middle)
BRISTOL-MYERS SQUIBB COMPANY, 345 PARK AVENUE
3. Date of Earliest Transaction (Month/Day/Year)
03/06/2012
(Street)

NEW YORK, NY 10154
4. If Amendment, Date Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.10 par value 03/06/2012   M   28,073(1) A $ 0 149,037 D  
Common Stock, $0.10 par value 03/06/2012   M   4,257(2) A $ 0 153,294 D  
Common Stock, $0.10 par value 03/06/2012   F   1,683(3) D $32.33 151,611 D  
Common Stock, $0.10 par value 03/06/2012   F   9,469(4) D $32.33 142,142 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Market Share Units (5) 03/06/2012   A   10,593     (6) 03/06/2016(6) Common Stock, $0.10 par value 10,593 $ 0 10,593 D  
Performance Shares (7) 03/06/2012   A   10,010(8)     (7)   (7) Common Stock, $0.10 par value 10,010 $ 0 36,854.93(9) D  
Performance Shares (10) 03/06/2012   A   9,789(11)     (10)   (10) Common Stock, $0.10 par value 9,789 $ 0 46,643.93(9) D  
Performance Shares (12) 03/06/2012   J   833.6523(13)     (12)   (12) Common Stock, $0.10 par value 833.6523 $ 0 47,477.5823(9) D  
Performance Shares (7) 03/06/2012   M     28,073(1)   (7)   (7) Common Stock, $0.10 par value 28,073 $ 0 19,404.5823(14) D  
Performance Shares (15) 03/06/2012   A   8,975(16)     (15) 03/31/2014(15) Common Stock, $0.10 par value 8,975 $ 0 8,975 D  
Performance Shares (17) 03/06/2012   J   403(18)     (17) 03/31/2014(17) Common Stock, $0.10 par value 403 $ 0 9,378 D  
Restricted Stock Units $ 0 (19) 03/06/2012   M     4,257 03/06/2010(2)   (2) Common Stock, $0.10 par value 4,257 $ 0 0 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Celentano John E
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK, NY 10154
      SVP HR Public Affairs & Philan  

Signatures

 /s/ Robert J. Wollin, attorney-in-fact for John E. Celentano   03/08/2012
** Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award.
(2) Represents vesting of one-third of restricted stock units granted on March 6, 2007. This award has fully vested.
(3) Shares withheld for payment of taxes upon vesting of restricted stock units.
(4) Shares withheld for payment of taxes upon distribution of the 2009-2011 Long-Term Performance Award.
(5) Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.
(6) Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.
(7) Each performance share converts into one share of common stock upon distribution in the first quarter of 2012.
(8) Represents performance shares earned under the 2009-2011 Long-Term Performance Award.
(9) This amount represents an aggregate of the derivative securities beneficially owned under the 2009-2011 and 2010-2012 Long-Term Performance Awards.
(10) Each performance share converts into one share of common stock upon distribution in the first quarter of 2013.
(11) Represents performance shares earned under the 2010-2012 Long Term Performance Award.
(12) Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013.
(13) Represents dividend equivalents earned under the 2010-2012 Long Term Performance Award.
(14) This amount represents an aggregate of the derivative securities beneficially owned under the 2010-2012 Long-Term Performance Award only.
(15) Each performance share converts into one share of common stock upon distribution in the first quarter of 2014.
(16) Represents performance shares earned under the 2011-2013 Long-Term Performance Award.
(17) Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014.
(18) Represents dividend equivalents earned under the 2011-2013 Long-Term Performance Award.
(19) Each restricted stock unit converts into one share of common stock upon vesting.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

XNYS:BMY Bristol-Myers Squibb Company Insider Activity 4 Filling

Bristol-Myers Squibb Company XNYS:BMY Stock - Get Insider Activity SEC Filing of Bristol-Myers Squibb Company XNYS:BMY stocks, including company profile, shares outstanding, strategy, business segments, operations, officers, consolidated financial statements, financial notes and ownership information.

XNYS:BMY Bristol-Myers Squibb Company Insider Activity 4 Filing - 3/6/2012
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Title |  Date |  Company |  Symbol |  Interest |  Popularity

Previous: XNYS:BMY Bristol-Myers Squibb Company Insider Activity 4 Filing - 3/6/2012  |  Next: XNYS:BMY Bristol-Myers Squibb Company Insider Activity 4 Filing - 3/6/2012